B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - All